Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trial of High Dose CoQ10 in ALS.

Trial Profile

Clinical Trial of High Dose CoQ10 in ALS.

Phase of Trial: Phase II

Latest Information Update: 16 Mar 2011

At a glance

  • Drugs Ubidecarenone (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Therapeutic Use
  • Acronyms QALS
  • Most Recent Events

    • 16 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 16 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top